Catalyst Wire Dossier Catalyst Wire Dossier

EDARBYCLOR

AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE · Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for EDARBYCLOR, covering 2011-12-20 to 2020-03-09. Get the full timeline:

Most recent: FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))

See pricing